2025-01-012025-12-312025-12-31false12774445TELESCOPE TECHNOLOGY LIMITED2026-08-2862012falseiso4217:GBPxbrli:pure127744452024-12-31127744452025-12-31127744452025-01-012025-12-31127744452023-12-31127744452024-12-31127744452024-01-012024-12-3112774445bus:SmallEntities2025-01-012025-12-3112774445bus:AuditExempt-NoAccountantsReport2025-01-012025-12-3112774445bus:FullAccounts2025-01-012025-12-3112774445bus:PrivateLimitedCompanyLtd2025-01-012025-12-3112774445core:WithinOneYear2025-12-3112774445core:AfterOneYear2025-12-3112774445core:WithinOneYear2024-12-3112774445core:AfterOneYear2024-12-3112774445core:ShareCapital2025-12-3112774445core:SharePremium2025-12-3112774445core:RevaluationReserve2025-12-3112774445core:OtherReservesSubtotal2025-12-3112774445core:RetainedEarningsAccumulatedLosses2025-12-3112774445core:ShareCapital2024-12-3112774445core:SharePremium2024-12-3112774445core:RevaluationReserve2024-12-3112774445core:OtherReservesSubtotal2024-12-3112774445core:RetainedEarningsAccumulatedLosses2024-12-3112774445core:LandBuildings2025-12-3112774445core:PlantMachinery2025-12-3112774445core:Vehicles2025-12-3112774445core:FurnitureFittings2025-12-3112774445core:OfficeEquipment2025-12-3112774445core:NetGoodwill2025-12-3112774445core:IntangibleAssetsOtherThanGoodwill2025-12-3112774445core:ListedExchangeTraded2025-12-3112774445core:UnlistedNon-exchangeTraded2025-12-3112774445core:LandBuildings2024-12-3112774445core:PlantMachinery2024-12-3112774445core:Vehicles2024-12-3112774445core:FurnitureFittings2024-12-3112774445core:OfficeEquipment2024-12-3112774445core:NetGoodwill2024-12-3112774445core:IntangibleAssetsOtherThanGoodwill2024-12-3112774445core:ListedExchangeTraded2024-12-3112774445core:UnlistedNon-exchangeTraded2024-12-3112774445core:LandBuildings2025-01-012025-12-3112774445core:PlantMachinery2025-01-012025-12-3112774445core:Vehicles2025-01-012025-12-3112774445core:FurnitureFittings2025-01-012025-12-3112774445core:OfficeEquipment2025-01-012025-12-3112774445core:NetGoodwill2025-01-012025-12-3112774445core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3112774445core:ListedExchangeTraded2025-01-012025-12-3112774445core:UnlistedNon-exchangeTraded2025-01-012025-12-3112774445core:MoreThanFiveYears2025-01-012025-12-3112774445core:Non-currentFinancialInstruments2025-12-3112774445core:Non-currentFinancialInstruments2024-12-3112774445dpl:CostSales2025-01-012025-12-3112774445dpl:DistributionCosts2025-01-012025-12-3112774445core:LandBuildings2025-01-012025-12-3112774445core:PlantMachinery2025-01-012025-12-3112774445core:Vehicles2025-01-012025-12-3112774445core:FurnitureFittings2025-01-012025-12-3112774445core:OfficeEquipment2025-01-012025-12-3112774445dpl:AdministrativeExpenses2025-01-012025-12-3112774445core:NetGoodwill2025-01-012025-12-3112774445core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3112774445dpl:GroupUndertakings2025-01-012025-12-3112774445dpl:ParticipatingInterests2025-01-012025-12-3112774445dpl:GroupUndertakingscore:ListedExchangeTraded2025-01-012025-12-3112774445core:ListedExchangeTraded2025-01-012025-12-3112774445dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-01-012025-12-3112774445core:UnlistedNon-exchangeTraded2025-01-012025-12-3112774445dpl:CostSales2024-01-012024-12-3112774445dpl:DistributionCosts2024-01-012024-12-3112774445core:LandBuildings2024-01-012024-12-3112774445core:PlantMachinery2024-01-012024-12-3112774445core:Vehicles2024-01-012024-12-3112774445core:FurnitureFittings2024-01-012024-12-3112774445core:OfficeEquipment2024-01-012024-12-3112774445dpl:AdministrativeExpenses2024-01-012024-12-3112774445core:NetGoodwill2024-01-012024-12-3112774445core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3112774445dpl:GroupUndertakings2024-01-012024-12-3112774445dpl:ParticipatingInterests2024-01-012024-12-3112774445dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3112774445core:ListedExchangeTraded2024-01-012024-12-3112774445dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3112774445core:UnlistedNon-exchangeTraded2024-01-012024-12-3112774445core:NetGoodwill2025-12-3112774445core:IntangibleAssetsOtherThanGoodwill2025-12-3112774445core:LandBuildings2025-12-3112774445core:PlantMachinery2025-12-3112774445core:Vehicles2025-12-3112774445core:FurnitureFittings2025-12-3112774445core:OfficeEquipment2025-12-3112774445core:AfterOneYear2025-12-3112774445core:WithinOneYear2025-12-3112774445core:ListedExchangeTraded2025-12-3112774445core:UnlistedNon-exchangeTraded2025-12-3112774445core:ShareCapital2025-12-3112774445core:SharePremium2025-12-3112774445core:RevaluationReserve2025-12-3112774445core:OtherReservesSubtotal2025-12-3112774445core:RetainedEarningsAccumulatedLosses2025-12-3112774445core:NetGoodwill2024-12-3112774445core:IntangibleAssetsOtherThanGoodwill2024-12-3112774445core:LandBuildings2024-12-3112774445core:PlantMachinery2024-12-3112774445core:Vehicles2024-12-3112774445core:FurnitureFittings2024-12-3112774445core:OfficeEquipment2024-12-3112774445core:AfterOneYear2024-12-3112774445core:WithinOneYear2024-12-3112774445core:ListedExchangeTraded2024-12-3112774445core:UnlistedNon-exchangeTraded2024-12-3112774445core:ShareCapital2024-12-3112774445core:SharePremium2024-12-3112774445core:RevaluationReserve2024-12-3112774445core:OtherReservesSubtotal2024-12-3112774445core:RetainedEarningsAccumulatedLosses2024-12-3112774445core:NetGoodwill2023-12-3112774445core:IntangibleAssetsOtherThanGoodwill2023-12-3112774445core:LandBuildings2023-12-3112774445core:PlantMachinery2023-12-3112774445core:Vehicles2023-12-3112774445core:FurnitureFittings2023-12-3112774445core:OfficeEquipment2023-12-3112774445core:AfterOneYear2023-12-3112774445core:WithinOneYear2023-12-3112774445core:ListedExchangeTraded2023-12-3112774445core:UnlistedNon-exchangeTraded2023-12-3112774445core:ShareCapital2023-12-3112774445core:SharePremium2023-12-3112774445core:RevaluationReserve2023-12-3112774445core:OtherReservesSubtotal2023-12-3112774445core:RetainedEarningsAccumulatedLosses2023-12-3112774445core:AfterOneYear2025-01-012025-12-3112774445core:WithinOneYear2025-01-012025-12-3112774445core:Non-currentFinancialInstrumentscore:CostValuation2025-01-012025-12-3112774445core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-012025-12-3112774445core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-012025-12-3112774445core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-012025-12-3112774445core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-012025-12-3112774445core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-012025-12-3112774445core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3112774445core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3112774445core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3112774445core:Non-currentFinancialInstrumentscore:CostValuation2025-12-3112774445core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-12-3112774445core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-12-3112774445core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-12-3112774445core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-12-3112774445core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-12-3112774445core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-12-3112774445core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-12-3112774445core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-12-3112774445core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3112774445core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3112774445core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3112774445core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3112774445core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3112774445core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3112774445core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3112774445core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3112774445core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3112774445bus:Director12025-01-012025-12-3112774445bus:Director22025-01-012025-12-31

TELESCOPE TECHNOLOGY LIMITED

Registered Number
12774445
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2025

TELESCOPE TECHNOLOGY LIMITED
Company Information
for the year from 1 January 2025 to 31 December 2025

Directors

CHAUDHARY, Humzah Shuaib
LASLETT, Oliver William, Dr

Registered Address

7 Bell Yard
London
WC2A 2JR

Registered Number

12774445 (England and Wales)
TELESCOPE TECHNOLOGY LIMITED
Balance Sheet as at
31 December 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets439,03516,764
39,03516,764
Current assets
Debtors5263,901260,087
Cash at bank and on hand295,75843,951
559,659304,038
Creditors amounts falling due within one year6(1,538,648)(129,961)
Net current assets (liabilities)(978,989)174,077
Total assets less current liabilities(939,954)190,841
Creditors amounts falling due after one year7(1,612,929)(1,639,827)
Net assets(2,552,883)(1,448,986)
Capital and reserves
Share premium1,338,1651,338,165
Other reserves722,785380,358
Profit and loss account(4,613,833)(3,167,509)
Shareholders' funds(2,552,883)(1,448,986)
The financial statements were approved and authorised for issue by the Board of Directors on 28 August 2026, and are signed on its behalf by:
CHAUDHARY, Humzah Shuaib
Director
Registered Company No. 12774445
TELESCOPE TECHNOLOGY LIMITED
Notes to the Financial Statements
for the year ended 31 December 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
The financial statements have been prepared on the going concern basis notwithstanding the fact that the company has a deficiency on shareholders' funds at the period end. The director considers the basis to be appropriate as the parent company, Telescope Technology Inc, has sufficient reserves to support the company to trade for a minimum of 12 months from the date of approval of the financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services.
Defined contribution pension plan
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to the income statement in the period to which they relate.
Share-based payments
The share-based payment has been accounted for as an equity-settled transaction in accordance with FRS 102 Section 26. The fair value of the options at the grant date is recognised as an expense over the vesting period, with a corresponding credit to a capital contribution reserve in equity as the share options granted relate to a parent entity's share capital. The capital contribution reserve is labelled as Other reserves on the balance sheet.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Office Equipment3
Financial instruments
The company recognises financial assets and financial liabilities when it becomes a party to the contractual provisions of the instrument. Financial assets comprise trade and other debtors, including loan notes, bonds and amount receivable under merchant cash advance arrangements. These assets are initially measured at the transaction price, including directly attributable transaction costs where applicable, and are subsequently measured at amortised cost less impairment. Financial liabilities comprise trade and other creditors and borrowings. These liabilities are initially measured at the transaction price and are subsequently measured at the amortised cost. The directors have elected to transfer the interest expense arising on loans measured at amortised cost from retained earnings to the capital contribution reserve. This transfer is presented as a movement within equity and does not affect the Company's profit or loss for the year. The company does not hold or issue derivative financial instruments.
2.Average number of employees

20252024
Average number of employees during the year86
3.Prior period adjustment
During the year, the company identified that share-based payment transactions relating to share option awards in the prior year had not been recognised in accordance with Section 26 Share-based Payment of FRS 102. In accordance with Section 10 of FRS 102 Accounting Policies, Estimates and Errors, this has been treated as the correction of a prior period error. The effect of the adjustment on the prior year increased operating expenses by £380,358, increased the loss before tax by £380,358, and increased other reserves by £380,358. The balance sheet impact is summarised below: Previously Reported Adjustment Restated Administrative Expenses £1,953,947 £380,358 £2,334,306 Profit and loss account (£2,787,151) (£380,358) (£3,167,509) Other reserves £nil £380,358 £380,358 Shareholders' funds (£1,448,986) £nil (£1,448,986) There is no impact on the company's cash balances or net assets, and the comparative figures for the prior year have been restated accordingly.
4.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 January 2538,70838,708
Additions37,07637,076
At 31 December 2575,78475,784
Depreciation and impairment
At 01 January 2521,94421,944
Charge for year14,80514,805
At 31 December 2536,74936,749
Net book value
At 31 December 2539,03539,035
At 31 December 2416,76416,764
5.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables39,852-
Other debtors191,534223,614
Prepayments and accrued income32,51536,473
Total263,901260,087
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables83,93315,748
Bank borrowings and overdrafts18-
Amounts owed to related parties910,380-
Taxation and social security83,21624,442
Other creditors4151,316
Accrued liabilities and deferred income460,68688,455
Total1,538,648129,961
7.Creditors: amounts due after one year

2025

2024

££
Amounts owed to related parties1,612,9291,639,827
Total1,612,9291,639,827
At the balance sheet date, the company owed £2,523,308 (2024: £1,639,827) to the parent company, Telescope Technology Inc, based in the US. £1,612,928 of the total amount is unsecured , interest free and repayable at the earlier of 31 August 2027 or any date in which the parties cease to be in the same corporate group. The remaining balance of £910,380 is unsecured, interest free and repayable on demand and included in note 6. The £1,612,928 has been discounted using a market rate of interest of 10%, which has given rise to a capital contribution reserve of £302,797. During the year interest of £56,295 was charged and this interest has been transferred from retained earnings to the capital contribution reserve. The remaining balance within the capital contribution reserve as at 31 December 2025 relating to the amortised loan is £246,502, which is included within Other Reserves in equity.
8.Operating lease commitments
At 31 Dec 2025, the company had total commitments under non-cancellable operating leases over the remaining life of those leases of £14,575 (2024 – £nil).
9.Controlling party
The Company is a wholly owned subsidiary of Telescope Technologies Inc, a company incorporated in 2020. Telescope Technologies Inc is both the Company's immediate and ultimate parent undertaking.
10.Further information regarding the company's financial position
The company identified share-based payment arrangements operated by the Company’s parent undertaking during the current year which existed in prior periods. The impact on prior year profit and net assets was assessed to be material and corrected as a prior period adjustment. Please see note 3 for further information. During the year, 260,981 options with an exercise price of £0.69 ($0.93) were granted. The options vest over a four-year period. During the year, 8,334 options were forfeited and 297,953 options were exercised. The fair value of the share options has been valued at £0.728292 ($0.93) based on an independent valuation and the 2024 funding round. The number and weighted average exercise price (WAEP) of the shares were as follows: Number of options WAEP (£) As at 1 January 2025 798,776 0.044626 Granted 260,981 0.690000 Exercised (297,953) 0.044626 Forfeited (8,334) 0.044626 As at 31 December 2025 753,470 0.268166 The value of the options recognised as an expense during the year was £95,924 (2024: £380,358). The total carrying amount recognised as a capital contribution reserve within Other Reserves in equity at 31 December 2025 was £476,282 (2024: £380,358).